The National Committee for Quality Assurance (NCQA) and the Robert Wood Johnson Foundation (RWJF) announced a new approach to measuring quality that will provide a more sensitive gauge of risk factors and make it possible to create clinically meaningful incentives for providers to improve disease prevention.
Under a grant from RWJF, NCQA will evaluate a new measurement tool that focuses on improving the health outcomes of patients with heart disease and diabetes. The “Global Cardiovascular Risk” (GCVR) score, which is being co-developed by NCQA and Archimedes, Inc., is the “next generation” quality improvement tool that measures how well providers reduce the risk of future adverse outcomes – such as heart attacks, strokes, and diabetic complications – in the populations they serve. GCVR is also a powerful new use of electronic health records (EHRs), drawing upon clinical information from EHRs to provide the data needed to assess improvement in preventing bad outcomes.
Read full news release: http://www.ncqa.org/Newsroom/2013NewsArchives/NewsReleaseApril92013.aspx